Advertisement
Screener

Ionis Pharmaceuticals, Inc. (IONS) Available-for-sale Securities, Amortized Cost Basis

2.2 / 5 stars · 52/118 Roast Me

Ionis Pharmaceuticals, Inc. Available-for-sale Securities, Amortized Cost Basis

Ionis Pharmaceuticals, Inc. (IONS) had Available-for-sale Securities, Amortized Cost Basis of $1.87 billion as of 2018-12-31, per its 10-K filed 2019-03-01.

Discontinued › Notes › Investments

us-gaap:AvailableForSaleSecuritiesAmortizedCost · last filed 2019-03-01

  • 2018-12-31: Available-for-sale Securities, Amortized Cost Basis $1.87B.
  • 2017-09-30: Available-for-sale Securities, Amortized Cost Basis $855.07M.
  • 2016-12-31: Available-for-sale Securities, Amortized Cost Basis $593.87M.
  • 2016-09-30: Available-for-sale Securities, Amortized Cost Basis $628.45M.
Period endAvailable-for-sale Securities, Amortized Cost BasisAvailable-for-sale Securities, Amortized Cost Basis as first filed
2018-12-31$1.87B
10-K · filed 2019-03-01
2017-09-30$855.07M
10-Q · filed 2017-11-07
2016-12-31$593.87M
10-K · filed 2018-02-28
2016-09-30$628.45M
10-Q · filed 2016-11-09
2016-06-30$594.10M
10-Q · filed 2016-08-09
2016-03-31$623.18M
10-Q · filed 2016-05-05
2015-12-31$667.62M
10-K · filed 2017-03-01
2015-09-30$701.96M
10-Q · filed 2015-11-09
2014-12-31$619.37M
10-K · filed 2016-02-26
$620.25M
10-Q · filed 2015-11-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
Spyre Therapeutics, Inc. (SYRE)United States$7.685B-43.69
Structure Therapeutics Inc. (GPCR)United States$7.710B-53.41
Alkermes plc. (ALKS)$6.844B132.74
RHYTHM PHARMACEUTICALS, INC. (RYTM)United States$6.771B-37.20
Praxis Precision Medicines, Inc. (PRAX)United States$7.884B-27.60
Liquidia Corp (LQDA)United States$6.347B51.23
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10